+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Compounding Pharmacy Market Analysis by Product (Topical Medications, Oral Medications, Suppositories), by Therapeutic Area (Hormone Replacement Medications, Pain Medications, Dermatological Applications), and by Region - Forecast to 2029

  • PDF Icon

    Report

  • 149 Pages
  • March 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5607041
The global compounding pharmacy market size is estimated to be USD 9.2 billion and is expected to witness a CAGR of 9.45% during the forecast period. Rise in global geriatric population and better life expectancy is a key driver for the growth of the global compounding pharmacy market. Additionally, growth in adoption of modified medicine in the developed economies and scarcity of drugs across the globe in the compounding pharmacy market are some of the other drivers propelling the market growth. Nevertheless, shortage of skilled pharmacists and lab technicians in the developing economies and high cost of equipment and upkeep of disinfected environment are expected to restrain the global market growth.

By Product


Based on product, the market is segmented into topical medications, oral medications, suppositories, and others. In the oral medications segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the increase in application of this form of medications such as capsules and tablets for various ailments worldwide. Topical medications segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in market for hormone replacement therapies and the rise in demand from the dermatological applications.

By Therapeutic Area


Based on therapeutic area, the market is segmented into hormone replacement medications, pain medications, dermatological applications, and others. In the pain medications segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the growth in prevalence of chronic pain amongst adults this is due to deskbound lifestyle or trauma owing to accidents worldwide. Hormone replacement medications segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in number of patients showing positive acceptance for hormone replacement therapy medications.

Regional Insights


In North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in demand for custom-made dosages, inventive therapeutic areas, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the accessibility of technological advanced products, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and availability of raw material used for manufacturing these medications at economic costs, are the major factors in this region. Competitor Insights Some of the key players in the compounding pharmacy market are F Fagron, Inc. (U.S.); Triangle Compounding Pharmacy (U.S.); B.Braun Melsungen AG (Germany); PharMEDium Healthcare Holdings, Inc. (U.S.); Fresenius Kabi AG (Germany); Avella Specialty Pharmacy (U.S.); Vertisis Custom Pharmacy (U.S.); US Compounding Inc. (U.S.); Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd. (India); and Elixir Compounding Pharmacy (Australia). The leading players operating in the compounding pharmacy industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The compounding pharmacy market report is categorized into the following segments and subsegments:

Compounding Pharmacy Market, By Product (Revenue, USD Billion, 2021 - 2029)

  • Topical Medications
  • Oral Medications
  • Suppositories
  • Others

Compounding Pharmacy Market, By Therapeutic Area (Revenue, USD Billion, 2021 - 2029)

  • Hormone Replacement Medications
  • Pain Medications
  • Dermatological Applications
  • Others

Compounding Pharmacy Market, By Region (Revenue, USD Billion, 2021 - 2029)


North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
1.4.1. Research Models
1.4.1.1. Bottom-up Approach
1.4.1.2. Top-down Approach
1.4.1.3. Data Triangulation
1.4.2. Data Procurement
1.4.2.1. Internal Database
1.4.2.2. Secondary Research
1.4.2.3. Purchased Database
1.4.2.4. Primary Research
1.4.3. Data Analysis
1.4.3.1. Data Validation
1.4.3.2. Market Size Estimation
1.4.3.3. Market Forecast Model
1.4.4. Quality Assessment
2. Introduction: Compounding Pharmacy
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Compounding Pharmacy Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1. Topical Medications
7.1.1. Topical Medications Market Forecast, 2021-2029 (USD Million)
7.2. Oral Medications
7.2.1. Oral Medications Market Forecast, 2021-2029 (USD Million)
7.3. Suppositories
7.3.1. Suppositories Market Forecast, 2021-2029 (USD Million)
7.4. Others
7.4.1. Others Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Therapeutic Area
8.1. Hormone Replacement Medications
8.1.1. Hormone Replacement Medications Market Forecast, 2021-2029 (USD Million)
8.2. Pain Medications
8.2.1. Pain Medications Market Forecast, 2021-2029 (USD Million)
8.3. Dermatological Applications
8.3.1. Dermatological Applications Market Forecast, 2021-2029 (USD Million)
8.4. Others
8.4.1. Others Market Forecast, 2021-2029 (USD Million)
9. Regional Market Analysis
9.1. Regional Market Trends
9.2. Regional Market: Comparative Analysis
10. North America Compounding Pharmacy Market
10.1. North America Compounding Pharmacy Market
10.1.1. North America Market Size and Forecast, 2021-2029 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
10.1.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
10.2. U.S. Compounding Pharmacy Market
10.2.1. U.S. Market Size and Forecast, 2021-2029 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
10.2.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
10.3. Canada Compounding Pharmacy Market
10.3.1. Canada Market Size and Forecast, 2021-2029 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
10.3.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11. Europe Compounding Pharmacy Market
11.1. Europe Compounding Pharmacy Market
11.1.1. Europe Market Size and Forecast, 2021-2029 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.1.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11.2. Germany Compounding Pharmacy Market
11.2.1. Germany Market Size and Forecast, 2021-2029 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.2.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11.3. UK Compounding Pharmacy Market
11.3.1. UK Market Size and Forecast, 2021-2029 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.3.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11.4. France Compounding Pharmacy Market
11.4.1. France Market Size and Forecast, 2021-2029 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.4.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11.5. Spain Compounding Pharmacy Market
11.5.1. Spain Market Size and Forecast, 2021-2029 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.5.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11.6. Italy Compounding Pharmacy Market
11.6.1. Italy Market Size and Forecast, 2021-2029 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.6.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
11.7. Rest of Europe Compounding Pharmacy Market
11.7.1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
11.7.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12. Asia Pacific Compounding Pharmacy Market
12.1. Asia Pacific Compounding Pharmacy Market
12.1.1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12.2. Japan Compounding Pharmacy Market
12.2.1. Japan Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12.3. China Compounding Pharmacy Market
12.3.1. China Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12.4. India Compounding Pharmacy Market
12.4.1. India Market Size and Forecast, 2021-2029 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.4.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12.5. South Korea Compounding Pharmacy Market
12.5.1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.5.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12.5.1.3. Market Size and Forecast by Device, 2021-2029 (USD Million)
12.6. Australia Compounding Pharmacy Market
12.6.1. Australia Market Size and Forecast, 2021-2029 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.6.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
12.7. Rest of Asia Pacific Compounding Pharmacy Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
12.7.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
13. Latin America Compounding Pharmacy Market
13.1. Latin America Compounding Pharmacy Market
13.1.1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
13.2. Brazil Compounding Pharmacy Market
13.2.1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
13.3. Mexico Compounding Pharmacy Market
13.3.1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
13.4. Argentina Compounding Pharmacy Market
13.4.1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
13.5. Rest of Latin America Compounding Pharmacy Market
13.5.1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
14. MEA Compounding Pharmacy Market
14.1. MEA Compounding Pharmacy Market
14.1.1. MEA Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
14.2. GCC Compounding Pharmacy Market
14.2.1. GCC Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
14.3. South Africa Compounding Pharmacy Market
14.3.1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
14.4. Rest of MEA Compounding Pharmacy Market
14.4.1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.2. Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
15. Competitor Analysis
15.1. Market Share Analysis, 2021 & 2029
15.2. Competitive Mapping
15.3. Key Players Market Place Analysis
15.4. Major Recent Developments
16. Company Profiles
16.1. F Fagron, Inc. (U.S.)
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financials
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Triangle Compounding Pharmacy (U.S.)
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financials
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. B.Braun Melsungen AG (Germany)
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financials
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. PharMEDium Healthcare Holdings, Inc. (U.S.)
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financials
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. Fresenius Kabi AG (Germany)
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financials
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. Avella Specialty Pharmacy (U.S.)
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financials
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. Vertisis Custom Pharmacy (U.S.)
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financials
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. US Compounding Inc. (U.S.)
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financials
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financials
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. Elixir Compounding Pharmacy (Australia)
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financials
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Company 11
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Product Benchmarking
16.11.5. Recent Developments
16.12. Company 12
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Product Benchmarking
16.12.5. Recent Developments
16.13. Company 13
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Product Benchmarking
16.13.5. Recent Developments
16.14. Company 14
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Product Benchmarking
16.14.5. Recent Developments
16.15. Company15
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Product Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players
17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F Fagron Inc. (U.S.)
  • Triangle Compounding Pharmacy (U.S.)
  • B.Braun Melsungen AG (Germany)
  • PharMEDium Healthcare Holdings Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Avella Specialty Pharmacy (U.S.)
  • Vertisis Custom Pharmacy (U.S.)
  • US Compounding Inc. (U.S.)
  • Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
  • Elixir Compounding Pharmacy (Australia)